We are living in an era of rapid technological innovation, which is permeating every area of our lives. Increasingly this will include the management of our health and care. This technological revolution is opening up new areas in our understanding, detection and treatment of disease.
Through these innovations we are entering into a new era of healthcare called ‘precision medicine’ which holds the promise of more personalised health and care. Advances in DNA analysis for the diagnosis and targeted treatment of diseases, such as cancer; point of care testing for infection control and the use of Artificial Intelligence to support clinical decision making together with digitally connected health records are just a few examples of how technology will support the provision of personalised care.

In Wales, our journey towards precision medicine is well underway and I am confident that we can be a front runner in the global race to harness the potential of precision medicine. It is vital that we have a connected and collaborative approach towards precision medicine and that our story is heard both in and outside Wales as an example of good practice and of working together towards a common set of goals. NHS Wales is on the cusp of realising the significant benefits that can be delivered from providing the right test or treatment to the right patient at the right time. The continuing evolution of precision medicine will help us to mitigate the escalating costs we face from providing excellent healthcare to an ageing population whilst providing more care closer to home. Our long term plan “A Healthier Wales” recognises the importance of moving towards earlier detection and intervention which is designed to prevent illness and prolong independence.

Advanced Therapies Wales is one of four national programmes within the Welsh Government’s Precision Medicine Portfolio. The Precision Medicine Portfolio also includes:

  • Genomics Partnerships Wales: who lead primarily on the platforms and advances needed in genomics and related bioinformatics to underpin precision medicine.
  • Pathology Statement of Intent programme: who make improvements in diagnostic services that can help transform the patient pathway and patient experience and lead to better patient outcomes, improved benefits for NHS Wales and support economic development.
  • Imaging Statement of Intent programme: who develop high quality, effective and sustainable imaging services for NHS Wales that address the needs of the population, respond to current and future policy direction and ensure long term sustainability.

To read more, click here

Contact
Get in touch today
F:01443 622 199
Welsh Blood Service, Ely Valley Road, Talbot Green, Pontyclun, CF72 9WB